NEW YORK (GenomeWeb News) – Illumina reported after the close of the market Monday that its first-quarter revenues increased 21 percent year over year as the firm swung to a loss due to litigation-related charges.

The San Diego-based firm posted revenues of $331 million for the three months ended March 31, compared to $272.8 million for the first quarter of 2012. It beat the average analyst estimate of $310.7 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.